Molnupiravir by Merck
Posted inTherapeutics

Molnupiravir

Merck Sharp and Dohme (MSD) developed molnupiravir in collaboration with Ridgeback Biotherapeutics. "Molnupiravir is the oral prodrug of beta-D-N4-hydroxycytidine (NHC), a ribonucleoside that has shown antiviral activity against SARS-CoV-2 in vitro and in clinical trials. NHC uptake by viral RNA-dependent…
19 October 2022Posted inTherapeutics
Paxlovid by Pfizer
Posted inTherapeutics

Paxlovid by Pfizer

PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets, co-packaged for oral use) is an anti-viral, patented drug by Pfizer. TGA: PAXLOVID: nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack. ClinicalTrials.gov: Evaluation of Protease Inhibition for COVID-19 in…
10 May 2022Posted inTherapeutics
Help me breathe
Posted inEarly Treatment Therapeutics

Budesonide

Patients having breathing issues was a big issue that doctors faced when treating COVID-19 symptoms in early 2020. Budesonide is a cheap drug that helps alleviate breathing issues. This page tracks the the early journey of Dr Richard Bartlett and…
19 February 2021Posted inEarly Treatment, Therapeutics